This analysis revealed that Toll activation by dsCactus treatment significantly reduced AnCPV infection prevalence as compared with the dsGFP controls (Fig. 4; combined p = 0.0013, chi-square = 21.8, df = 6). The gene discussed is TLR4; the disease is infection.